EPISODE · Jun 8, 2021 · 41 MIN
Sponsored: After COVID-19, are we better prepared for the next pandemic?
from Next Question with Katie Couric
On this sponsored episode of Next Question with Katie Couric, Katie sits down with Dr. Julie L. Gerberding, the executive vice president and chief patient officer of the biopharmaceutical company Merck. As a company with a long legacy of research in infectious disease, Merck has been in the thick of the COVID crisis, mobilizing its scientific expertise to help address the pandemic. Katie and Dr. Gerberding talk about the waning months of this historic pandemic, the lingering concerns about vaccinations and variants, COVID’s lasting impact on public health and how we can better prepare for emerging diseases. Merck is a partner of Katie Couric Media. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
On this sponsored episode of Next Question with Katie Couric, Katie sits down with Dr. Julie L. Gerberding, the executive vice president and chief patient officer of the biopharmaceutical company Merck. As a company with a long legacy of research in infectious disease, Merck has been in the thick of the COVID crisis, mobilizing its scientific expertise to help address the pandemic. Katie and Dr. Gerberding talk about the waning months of this historic pandemic, the lingering concerns about vaccinations and variants, COVID’s lasting impact on public health and how we can better prepare for emerging diseases. Merck is a partner of Katie Couric Media. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
Sponsored: After COVID-19, are we better prepared for the next pandemic?
No transcript for this episode yet
Similar Episodes
No similar episodes found.